LEPU MED.T.B. SP.GDR O.N. (07Z0) - Total Liabilities
Based on the latest financial reports, LEPU MED.T.B. SP.GDR O.N. (07Z0) has total liabilities worth €7.61 Billion EUR (≈ $8.90 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore LEPU MED.T.B. SP.GDR O.N. equity growth rate to track the company's year-over-year net asset growth rate.
LEPU MED.T.B. SP.GDR O.N. - Total Liabilities Trend (2021–2025)
This chart illustrates how LEPU MED.T.B. SP.GDR O.N.'s total liabilities have evolved over time, based on quarterly financial data. See how much free cash does LEPU MED.T.B. SP.GDR O.N. generate to measure how efficiently the company converts operating cash flow to free cash.
LEPU MED.T.B. SP.GDR O.N. Competitors by Total Liabilities
The table below lists competitors of LEPU MED.T.B. SP.GDR O.N. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
iomart Group plc
LSE:IOM
|
UK | GBX186.18 Million |
|
Kropz Plc
LSE:KRPZ
|
UK | GBX89.51 Million |
|
Pennant International Group plc
LSE:PEN
|
UK | GBX5.25 Million |
|
Virgin Wines UK PLC
LSE:VINO
|
UK | GBX18.50 Million |
|
Tavistock Investments Plc
LSE:TAVI
|
UK | GBX12.56 Million |
|
Georgina Energy PLC
LSE:GEX
|
UK | GBX3.62 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down LEPU MED.T.B. SP.GDR O.N.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see LEPU MED.T.B. SP.GDR O.N. market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.38 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.46 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how LEPU MED.T.B. SP.GDR O.N.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for LEPU MED.T.B. SP.GDR O.N. (2021–2025)
The table below shows the annual total liabilities of LEPU MED.T.B. SP.GDR O.N. from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €8.38 Billion ≈ $9.80 Billion |
+6.97% |
| 2024-12-31 | €7.83 Billion ≈ $9.16 Billion |
+4.09% |
| 2023-12-31 | €7.52 Billion ≈ $8.80 Billion |
-7.25% |
| 2022-12-31 | €8.11 Billion ≈ $9.49 Billion |
-3.70% |
| 2021-12-31 | €8.43 Billion ≈ $9.85 Billion |
-- |
About LEPU MED.T.B. SP.GDR O.N.
Lepu Medical Technology (Beijing) Co., Ltd., together with its subsidiaries, engages in the research, development, and manufacturing of cardiac interventional medical devices in China and internationally. The company operates through three segments: Medical Devices; Pharmaceuticals; and Medical Services and Health Management. It offers medical devices, including cardiovascular devices, in vitro d… Read more